IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer. - Hack SP; Verret W; Mulla S; Liu B; Wang Y; Macarulla T; Ren Z; El-Khoueiry AB; Zhu AX (Therapeutic advances in medical oncology, 2021)